
Sign up to save your podcasts
Or
This week’s View summarizes articles about whether there are differences in daily symptom scores on statin, placebo, and no treatment in participants who had abandoned statins; the safety and immunogenicity of heterologous schedules with different coronavirus disease 2019 (COVID-19) vaccines; and the effectiveness of inhaled budesonide in reducing recovery time and rates of COVID-19-related hospital admission or death in people at high risk of an adverse outcome.
4.7
127127 ratings
This week’s View summarizes articles about whether there are differences in daily symptom scores on statin, placebo, and no treatment in participants who had abandoned statins; the safety and immunogenicity of heterologous schedules with different coronavirus disease 2019 (COVID-19) vaccines; and the effectiveness of inhaled budesonide in reducing recovery time and rates of COVID-19-related hospital admission or death in people at high risk of an adverse outcome.
131 Listeners
322 Listeners
161 Listeners
861 Listeners
491 Listeners
32 Listeners
278 Listeners
87 Listeners
1,087 Listeners
61 Listeners
39 Listeners
185 Listeners
348 Listeners
420 Listeners
37 Listeners